Paras Healthcare Limited IPO

Paras Healthcare Limited IPO

Bidding period

To be announced

Bid price

To be announced

Listing on

To be announced

Listing date

To be announced

Lot size

To be announced

Issue size

To be announced


Minimum investment

To be announced

Maximum investment

To be announced

EXPLORE IPOs
EXPLORE IPOs

Paras Healthcare Limited IPO financials

Particulars

For the period ending in March 2024 (in ₹ million)

Total assets ₹1,477.66
Total liabilities ₹1,477.66
Total expenditure ₹1,157.78
Total revenue ₹1,164.41
Profit after tax -₹15.33
EBITDA ₹154.41
Adjusted EBITDA ₹0.00

Paras Healthcare Limited shareholder pattern

Pre-issue Post-issue
Promoter group 0.0 0.0
Public group 0.0 0.0

Paras Healthcare Limited strengths and risks

Information currently unavailable

  • Fifth largest healthcare provider in terms of bed capacity in North India, Bihar and Jharkhand among our Peers, with an aggregate of 2,135 beds, as of March 31, 2024.

  • Asset light business model with several initiatives to drive patient access and performance.

  • Delivering quality clinical care by attracting and retaining renowned clinicians.

  • Diversified operations across clinical specialties, payor mix and hospitals.

  • Robust operating infrastructure across our hospitals including information technology and modern equipment.

  • Doctor led professional management team with proven execution capabilities.

  • We have incurred loss for the year of Rs. 153.31 million, Rs. 427.92 million and Rs. 148.08 million during Fiscal 2024, Fiscal 2023 and Fiscal 2022, respectively. We cannot assure you that we will generate profits and not incur losses in the future.

  • We are highly dependent on doctors, nurses and other healthcare professionals and if we are unable to attract, retain or train such professionals, our business, results of operations and financial condition may be adversely affected.

  • All of our hospitals are located in North India, including, the four hospitals which have been operational for over five years and on which we are dependent for a significant portion of our revenues. Consequently, any adverse.

  • We generate a significant portion of our revenues from the provision of cardiac sciences, oncology, neuro sciences and gastro sciences specialties which contributed 59.58%, 58.41% and 54.00% of our revenue from operations for Fiscal 2024, 2023 and 2022, respectively. Any adverse developments in the demand for such services or changes in technology could render such offerings obsolete and could adversely affect our business, results of operations and financial condition.

  • The provision of healthcare services involves high costs such as employee benefit expenses, rent and facility fees, retainers and consultants fee and purchase of equipment and consumables, which we may fail to pass on to patients, which could adversely affect our business, results of operations and financial condition.

  • Regulatory reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing including any regulation to provide uniform pricing and discounted pricing for all patients could adversely affect our business, results of operations and financial condition.

  • We may not be successful in expanding our hospital network, developing our proposed hospitals and may not achieve operating capacities that we anticipate, any of which could adversely affect our business, results of operations, financial condition and prospects.

  • We are dependent on revenue generated from our in-patient department. If we are unable to maintain and increase our hospital occupancy rates, our operating efficiencies and profitability may be adversely affected.

  • Our business depends on the strength of our brand and reputation and any negative publicity or allegations in the media against us, may adversely affect the level of trust in our services and have an adverse effect on our business, financial condition, results of operations and prospects.

  • We operate most of our hospitals through revenue share arrangements and long term leases and any adverse developments in our relationships with our counter parties, or our inability to renew such leases could adversely affect our ability to operate such hospitals.

How to check the allotment status of the Paras Healthcare Limited IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Paras Healthcare Limited’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Paras Healthcare Limited’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

Paras Healthcare Limited IPO registrar

MUFG Intime India Pvt Ltd

Phone number +91 810 811 4949
E-mail ID parashealthcare.ipo@linkintime.co.in
Website www.linkintime.co.in

Paras Healthcare Limited IPO reservation

QIB shares offered

0 (0.0%)

NII (HNI) shares offered

0 (0.0%)

Retail shares offered

0 (0.0%)

Anchor investor shares offered

0 (0.0%)

Total shares offered

0

Total shares with anchor investor

0

Paras Healthcare Limited IPO lead manager

  • ICICI Securities Ltd
  • IIFL Securities Ltd
  • Motilal Oswal Investment Advisors Ltd

Explore other IPOs

Aditya Infotech Limited logo
Aditya Infotech Limited logo

Aditya Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advance Agrolife Limited logo
Advance Agrolife Limited logo

Advance Agrolife Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aegis Vopak Terminals Limited logo
Aegis Vopak Terminals Limited logo

Aegis Vopak Terminals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
All Time Plastics Limited logo
All Time Plastics Limited logo

All Time Plastics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Amanta Healthcare Limited logo
Amanta Healthcare Limited logo

Amanta Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anand Rathi Share AND Stock Brokers Limited logo
Anand Rathi Share AND Stock Brokers Limited logo

Anand Rathi Share AND Stock Brokers Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anlon Healthcare Limited logo
Anlon Healthcare Limited logo

Anlon Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anthem Biosciences Limited logo
Anthem Biosciences Limited logo

Anthem Biosciences Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AOne Steels India Limited logo
AOne Steels India Limited logo

AOne Steels India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ardee Engineering Limited logo
Ardee Engineering Limited logo

Ardee Engineering Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Armee Infotech Limited logo
Armee Infotech Limited logo

Armee Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Asirvad Microfinance Limited logo
Asirvad Microfinance Limited logo

Asirvad Microfinance Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Atlanta Electricals Limited logo
Atlanta Electricals Limited logo

Atlanta Electricals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Avanse Financial Services Limited logo
Avanse Financial Services Limited logo

Avanse Financial Services Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Paras Healthcare Limited IPO?

The listing date for the Paras Healthcare Limited IPO is unknown.

What is the issue size of Paras Healthcare Limited IPO?

The issue size of the Paras Healthcare Limited IPO is unknown cr.

What is the minimum lot size needed for Paras Healthcare Limited IPO?

The minimum lot size for Paras Healthcare Limited IPO is unknown

When does the Paras Healthcare Limited open and close?

Paras Healthcare Limited IPO is open from unknown to unknown.

How can I apply for the Paras Healthcare Limited IPO?

To apply for the Paras Healthcare Limited, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)